Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2018

01-10-2018 | Breast Oncology

Should Reexcision Rates in Breast Cancer Care be a Quality Measure?

Authors: Anees B. Chagpar, MD, MSc, MPH, MA, MBA, Lee G. Wilke, MD

Published in: Annals of Surgical Oncology | Issue 10/2018

Login to get access

Excerpt

Quality measurement and reporting in breast cancer surgery have been emphasized increasingly. Both patients and payers are interested in more transparency in cancer care, and accrediting bodies such as the Commission on Cancer and the National Accreditation Program of Breast Centers (NAPBC) are building quality metrics into established standards to reduce disparities and improve cancer outcomes. …
Literature
1.
Chassin MR, Loeb JM, Schmaltz SP, et al. Accountability measures: using measurement to promote quality improvement. N Engl J Med. 2010; 363:683–8.CrossRefPubMed
2.
Houssami N, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21:717–30.CrossRefPubMedPubMedCentral
3.
Chagpar AB, Horowitz NR, Killelea BK, et al. Economic impact of routine cavity margins versus standard partial mastectomy in breast cancer patients: results of a randomized controlled trial. Ann Surg. 2017;265(1):39–44.CrossRef
4.
Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 2014;21:704–16.CrossRefPubMed
5.
Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503–10.CrossRefPubMedPubMedCentral
6.
Landercasper J, Attai D, Atisha D, et al. Toolbox to reduce lumpectomy reoperations and improve cosmetic outcome in breast cancer patients: the American Society of Breast Surgeons Consensus Conference. Ann Surg Oncol. 2015;22:3174–83.CrossRefPubMedPubMedCentral
7.
Schulman AM, Mirrielees JA, Leverson G, et al. Reexcision surgery for breast cancer: an analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO “No Ink on Tumor” Guidelines. Ann Surg Oncol. 2017;24(1):52–58.CrossRefPubMed
8.
Rosenberger LH, Mamtani A, Fuzesi S, et al. Early adoption of the SSO-ASTRO consensus guidelines on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer: initial experience from Memorial Sloan Kettering Cancer Center. Ann Surg Oncol. 2016;23:3239–46.CrossRefPubMedPubMedCentral
9.
Agarwal S, Pappas L, Neumayer L, et al. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014;149:267–74.CrossRefPubMed
10.
Isaacs AJ, Gemignani ML, Pusic A, et al. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York state. JAMA Surg. 2016;151:648–55.CrossRefPubMed
11.
Tang SS, Kaptanis S, Haddow JB, et al. Current margin practice and effect on reexcision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland. Eur J Cancer. 2017;84:315–24.CrossRefPubMed
12.
Horwitz RI. Equity in cancer care and outcomes of treatment: a different type of cancer moonshot. JAMA. 2016;315:1231–2.CrossRefPubMed
13.
14.
15.
16.
Graham RA, Homer MJ, Katz J, et al. The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg. 2002;184:89–93.CrossRefPubMed
17.
Guidi AJ, Tworek JA, Mais DD, et al. Breast specimen processing and reporting with an emphasis on margin evaluation: a College of American Pathologists survey of 866 laboratories. Arch Pathol Lab Med. 2018;142:496–506.CrossRefPubMed
18.
Patten CR, Walsh K, Sarantou T, et al. Changes in margin reexcision rates: experience incorporating the “no ink on tumor” guideline into practice. J Surg Oncol. 2017;116:1040–5.CrossRefPubMed
19.
Thill M, Baumann K, Barinoff J. Intraoperative assessment of margins in breast conservative surgery: still in use? J Surg Oncol. 2014;110:15–20.CrossRefPubMed
20.
Boughey JC, Keeney GL, Radensky P, et al. Economic implications of widespread expansion of frozen section margin analysis to guide surgical resection in women with breast cancer undergoing breast-conserving surgery. J Oncol Pract. 2016;12:e413–22.CrossRefPubMed
21.
Murphy BL, Boughey JC, Keeney MG, et al. Factors associated with positive margins in women undergoing breast conservation surgery. Mayo Clin Proc. 2018;93:429–35.CrossRefPubMed
22.
Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979–90.CrossRefPubMed
23.
Chagpar AB, Cicek AF, Harigopal M. Can tumor biology predict occult multifocal disease in breast cancer patients? Am Surg. 2017;83:704–8.PubMed
24.
Houssami N, Turner RM, Morrow M. Meta-analysis of preoperative magnetic resonance imaging (MRI) and surgical treatment for breast cancer. Breast Cancer Res Treat. 2017;165:273–83.CrossRefPubMedPubMedCentral
25.
Morrow M, Katz SJ. The challenge of developing quality measures for breast cancer surgery. JAMA. 2012;307:509–10.CrossRefPubMed
26.
Metadata
Title
Should Reexcision Rates in Breast Cancer Care be a Quality Measure?
Authors
Anees B. Chagpar, MD, MSc, MPH, MA, MBA
Lee G. Wilke, MD
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-6576-5

Other articles of this Issue 10/2018

Annals of Surgical Oncology 10/2018 Go to the issue

Breast Oncology

Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged < 50 Years versus ≥ 50 Years, and Trends Over Time

Breast Oncology

Timing and Delays in Breast Cancer Evaluation and Treatment

Breast Oncology

Impact of Breast Reconstruction on Time to Definitive Surgical Treatment, Adjuvant Therapy, and Breast Cancer Outcomes

Breast Oncology

Intraoperative Radiation Therapy (IORT): A Series of 1000 Tumors

Breast Oncology

Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast

Breast Oncology

Intraoperative Radiotherapy for Breast Cancer Treatment in a Rural Community